With a 0.2% average reported migration rate, GORE® VIABIL® Short Wire Biliary Endoprosthesis is the only fully covered metal stent with anti-migration technology proven to reduce the risk of reintervention. Gore is so confident in these outcomes, we offer an Anti-migration Assurance Program for GORE® VIABIL® Short Wire Biliary Endoprosthesis if a migration occurs.
Additional interventions increase the overall cost to treat:
- The average geometric mean cost of a hospital outpatient ERCP with stent placement for patients without complications is approximately $3,700 (CY2016 Hospital Outpatient Prospective Payment System (OPPS) Final Rule. Centers for Medicare & Medicaid Services Web site. Published November 13, 2015. Accessed December 14, 2016).
- The average cost of a hospital inpatient ERCP with stent placement for patients without complications is approximately $4,649 (National healthcare payer database, 2015).
- Based on migration data, for every 100 patients with stent placement, the use of GORE® VIABIL® Short Wire Biliary Endoprosthesis will potentially eliminate five device migrations (as compared to the closest competitive option), which is a savings of at least $23,000 (not including the cost of the stent)
Gore has used reasonable efforts to ensure the completeness and accuracy of the information contained herein as of the date this document was prepared. All the information and results from this application are provided “as is” without guaranty or warranty, either expressed or implied. Gore is not liable for any claims or actions attributable to the use of this application model, nor for any errors or omissions involved in the use of the application or the results. Payment policies are variable depending on the payer, geographic location and provider specific contracts. Therefore, the models provided herein are for illustrative purposes only and are not intended to be indicative of payment from any payer.